Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Gold, Herman K., MD.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Guidant Corporation
Information provided by:
Gold, Herman K., MD
ClinicalTrials.gov Identifier:
NCT00116792
First received: June 30, 2005
Last updated: May 15, 2007
Last verified: May 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given